RTN4R and atherosclerosis: To explore the potential mechanisms of NS in combating atherosclerosis, we employed network pharmacology approaches A total of 241 NGR1-related targets, 222 SSB2-related targets, and 4619 atherosclerosis-related targets were identified, with113 shared targets (Fig 1A).